Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Octreotide
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
Amber SPIS
Octreotide Olatuton
®
(Prolonged release suspension for injection)
Malignant disease and immunosuppression, Somatostatin analogues, 08.03.04.03
Amber SPIS
Octreotide Sandostatin Lar
®
Malignant disease and immunosuppression, Somatostatin analogues, 08.03.04.03
Amber SPIS
Octreotide 50mcg, 100mcg, 500mcg Sandostatin
®
(Injection)
Malignant disease and immunosuppression, Somatostatin analogues, 08.03.04.03
RED
Octreotide 50micrograms in 1mL
(Injection)
Emergency Treatment of Poisoning, Specific Drugs, 18
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Octreotide
Octreotide
Endocrine System, Hormone Responsive Malignancy, Pituitary And Hypothalamic Hormones And Analogues Somatostatin Analogues
Octreotide
Octreotide
Endocrine System, Hypothalamic And Anterior Pituitary Hormone Related Disorders, Growth Hormone Disorders, Pituitary And Hypothalamic Hormones And Analogues Somatostatin Analogues
Octreotide
Octreotide
Malignant Disease, Hormone Responsive Malignancy, Pituitary And Hypothalamic Hormones And Analogues Somatostatin Analogues